Status:
NO_LONGER_AVAILABLE
Pre-Approval Access to Pimodivir for the Treatment of Patients With H7N9 Influenza A Infection
Lead Sponsor:
Janssen Research & Development, LLC
Conditions:
H7N9 Subtype of Influenza A Virus
Eligibility:
All Genders
13+ years
Brief Summary
The purpose of this program is to provide pre-approval access to pimodivir for the treatment of a patient(s) with H7N9 influenza A infection. Pre-approval access pertains to provision for therapeutic ...
Eligibility Criteria
Inclusion
- The patient has an H7N9 Influenza A infection
- The patient has no known severe hepatic impairment
Exclusion
- \- Any other Influenza A sub-strains other than H7N9
Key Trial Info
Start Date :
Trial Type :
EXPANDED_ACCESS
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03834376
Last Update
October 28 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.